Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma

17 Feb 2021

Abstract excerpt

Objectives The study aims to analyze the expression of N6-methyladenosine (m6A)-modified genes in rectum adenocarcinoma (READ) and identify reliable prognostic biomarkers to predict the prognosis of READ. Materials and Methods RNA sequence data of READ and corresponding clinical survival data were obtained from The Cancer Genome Atlas (TCGA) database. N6-methyladenosine (m6A)-modified genes in READ were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33680913
DOI: 10.3389/fonc.2020.567931

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum AdenocarcinomaPMID 33680913Read ↗

Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal CancerSemantic proximity Read ↗

Gene signature and prognostic merit of M6a regulators in colorectal cancer.Semantic proximity Read ↗

Identification and Validation of m6A-GPI Signatures as a Novel prognostic Model for Colorectal CancerSemantic proximity Read ↗

Identification of Five m6A-Relevant mRNAs Signature and Risk Score for The Prognostication of Gastric CancerSemantic proximity Read ↗

Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA‐mRNA functional synergistic networkSemantic proximity Read ↗

Identification of N6-Methyladenosine-Related Gene Based Prognostic Signature to Predict Survival and Potential Therapeutic Drugs in GliomaSemantic proximity Read ↗

Prognostic Value of Drug Targets Predicted using Deep Bioinformatic Analysis of M6A-associated lncRNA-based Pancreatic Cancer Model Characteristics and its Tumour MicroenvironmentSemantic proximity Read ↗

N6-methyladenosine-related long noncoding RNA is a potential biomarker for predicting pancreatic cancer prognosisSemantic proximity Read ↗

Evaluated the Role of N6-Methyladenosine-associated lncRNAs in Prognosis and Immune Microenvironment of Colorectal CancerSemantic proximity Read ↗

Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.Semantic proximity Read ↗

Identification of the Signature Associated With m6A RNA Methylation Regulators and m6A-related Genes and Construction of the Risk Score for Prognostication in Early-stage Lung AdenocarcinomaSemantic proximity Read ↗

Gene Signature And Prognostic Values of m5C-Related Regulators In Colon AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.